X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (15) 15
infectious diseases (12) 12
middle aged (9) 9
adult (8) 8
epidemiology (8) 8
female (8) 8
male (8) 8
aged (7) 7
infectious disease (7) 7
mortality (7) 7
diagnosis (5) 5
mycoses (5) 5
young adult (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
allergic bronchopulmonary aspergillosis (4) 4
antifungal agents - therapeutic use (4) 4
fungi (4) 4
health aspects (4) 4
hiv (4) 4
human immunodeficiency virus--hiv (4) 4
incidence (4) 4
infections (4) 4
management (4) 4
medical research (4) 4
meningitis (4) 4
microbiology (4) 4
mycology (4) 4
mycoses - microbiology (4) 4
acquired immune deficiency syndrome--aids (3) 3
allergy (3) 3
antifungal agents (3) 3
antigens (3) 3
aspergillosis (3) 3
aspergillus fumigatus (3) 3
asthma (3) 3
asthma - complications (3) 3
disease (3) 3
fungal diseases (3) 3
fungal infections (3) 3
itraconazole (3) 3
lung diseases (3) 3
mycoses - diagnosis (3) 3
mycoses - epidemiology (3) 3
prevalence (3) 3
quality of life (3) 3
respiratory system (3) 3
retrospective studies (3) 3
therapy (3) 3
aids (2) 2
aids-related opportunistic infections - epidemiology (2) 2
antifungal agents - administration & dosage (2) 2
antifungal agents - adverse effects (2) 2
antiretroviral therapy (2) 2
aspergillosis, allergic bronchopulmonary - complications (2) 2
aspergillosis, allergic bronchopulmonary - drug therapy (2) 2
aspergillosis, allergic bronchopulmonary - epidemiology (2) 2
aspergillus (2) 2
asthma - epidemiology (2) 2
bacteria (2) 2
bacterial infections - epidemiology (2) 2
bronchoalveolar lavage fluid (2) 2
candidiasis (2) 2
cd4 lymphocyte count (2) 2
child (2) 2
child, preschool (2) 2
children (2) 2
chronic cavitary (2) 2
chronic disease (2) 2
clinical characteristics (2) 2
cohort (2) 2
colonization (2) 2
corticosteroids (2) 2
cryptococcal meningitis (2) 2
dermatology (2) 2
diabetes mellitus (2) 2
disease control (2) 2
diseases (2) 2
drug resistance in microorganisms (2) 2
environmental sciences (2) 2
estimates (2) 2
eukaryotic microbiology (2) 2
fungicides (2) 2
global burden (2) 2
health risks (2) 2
hiv infections - complications (2) 2
hiv infections - drug therapy (2) 2
immunoglobulin g (2) 2
income (2) 2
infant (2) 2
infant, newborn (2) 2
invasive pulmonary aspergillosis (2) 2
laboratories (2) 2
life sciences (2) 2
low income groups (2) 2
medical microbiology (2) 2
medical personnel (2) 2
medicine, experimental (2) 2
microbial ecology (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (2) 2
Criminology - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Knox College (Caven) - Storage (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 873 - 881
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 11, pp. 1136 - 1149
Summary The emergence and spread of antimicrobial-resistant bacterial, viral, and fungal pathogens for which diminishing treatment options are available is of... 
Infectious Disease | INFECTIOUS DISEASES | INFLUENZA-A | ASPERGILLUS-FUMIGATUS | IN-VITRO | VIRUS-INFECTION | A DOUBLE-BLIND | OPEN-LABEL | CRITICALLY-ILL PATIENTS | T-CELLS | SYNDROME CORONAVIRUS | H1N1 VIRUS | Mycoses - epidemiology | Virus Diseases - epidemiology | Biological Therapy - methods | Biological Therapy - trends | Humans | Drug Resistance, Viral | Drug Resistance, Bacterial | Mycoses - microbiology | Virus Diseases - virology | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Virus Diseases - drug therapy | Respiratory Tract Infections - virology | Drug Resistance, Fungal | Bacterial Infections - microbiology | Drug Therapy - trends | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Drug Discovery - trends | Respiratory Tract Infections - drug therapy | Treatment Outcome | Drug Therapy - methods | Bacterial Infections - epidemiology | Mycoses - drug therapy | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Antiviral agents | Hospitals | Influenza | Mycoses | Development and progression | Bacteria | Cross infection | Nosocomial infections | Drug therapy | Cells | Drug resistance in microorganisms | Severe acute respiratory syndrome | Respiratory agents | Pandemics | Mortality | Respiratory diseases | Viral infections
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 11/2018, Volume 18, Issue 11, pp. e339 - e347
Journal Article
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 11/2017, Volume 17, Issue 11, pp. e357 - e366
The human respiratory tract is exposed daily to airborne fungi, fungal enzymes, and secondary metabolites. The endemic fungi spp, , and , and occasionally ,... 
CLINICAL-PRACTICE GUIDELINES | INFECTIOUS DISEASES | HYPERSENSITIVITY PNEUMONITIS | PARANASAL SINUSES | MULTIPLE CHEMICAL-SENSITIVITY | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | BUILDING SICKNESS SYNDROME | CYSTIC-FIBROSIS | RESPIRATORY SYMPTOMS | CHRONIC RHINOSINUSITIS | AIRWAY DISEASE | Mycoses - epidemiology | Lung Diseases - diagnosis | Fungi - classification | Lung Diseases - microbiology | Sinusitis - diagnosis | Humans | Risk Factors | Fungi - isolation & purification | Mycoses - microbiology | Lung Diseases - drug therapy | Sinusitis - epidemiology | Antifungal Agents - therapeutic use | Mycoses - drug therapy | Sinusitis - microbiology | Mycoses - diagnosis | Lung Diseases - epidemiology | Sinusitis - drug therapy | Mycoses | Asthma in children | Immunoglobulin G | Allergy | Proteases | Antifungal agents | Allergic reaction | Risk factors | Plant metabolites | Cell culture | Therapy | Allergens | Pneumonia | Fungicides | Rhinosinusitis | Infections | Presentations | Fungi | Respiratory tract | Genotype & phenotype | Airborne microorganisms | Secondary metabolites | Sinuses | Metabolites | Sinus | Heterocyclic compounds | Fungal diseases | Nose | Bronchitis | Genetic factors | Children | Bacterial infections | Cell walls | Lung diseases | Health risks | Cystic fibrosis | Exposure | Risk analysis | Patients | Allergies | Asthma | Azoles | Microscopy | Sputum | Immunocompromised hosts | Viral infections
Journal Article
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 04/2019, Volume 19, Issue 4, pp. e143 - e147
Journal Article
Journal Article
Journal of Infection, ISSN 0163-4453, 2015, Volume 72, Issue 2, pp. 240 - 249
Summary Objectives Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million persons worldwide. Aspergillus -specific IgG is a key component in... 
Infectious Disease | Antigen | Aspergillus fumigatus | CPA | Aspergillosis | Aspergilloma | ELISA | GLOBAL BURDEN | ANTIBODIES | INFECTIOUS DISEASES | STABILITY | CLINICAL CHAR